| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/30/2002 | CN1333229A Novel polypeptide--TEGT protein 42.13 and polynucleotide for encoding this polypeptide |
| 01/30/2002 | CN1333228A Novel polypeptide--eukaryotic releasing factor 110.67 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333227A Novel polypeptide-cell surface protein TAPA-123.32 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333226A Novel polypeptide--butyrophilin 52.91 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333225A Novel polypeptide--oligodendrocyte-myelin glucoprotein 9.68 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333224A Novel polypeptide--LLRep3 ribosomal protein 11.88 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333223A Novel polypeptide--chromatin agregation protein 70 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333222A Novel polypeptide--degeorge syndrome key area 2-16.06 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333221A Novel polypeptide--human ubiquitin protein stable protein 9.02 and polynucleotide for coding said polypeptide |
| 01/30/2002 | CN1333220A Novel polypeptide--chromosome translocation related hot spot conjugated protein 9.79 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333218A Novel polypeptide--zinc finger protein 12.76 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333217A Novel polypeptide--pedalcalix protein similar pretein 9.46 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333216A Novel polypeptide--ring finger protein 151 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333215A Novel polypeptide--developmental regulation related protein 10.45 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333214A Novel polypeptide-four times membrane-spanning protein 14,19 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1333213A Novel polypeptide-cell signaling protein MyD 24.09 and polynucleotide for encoding said polypeptide |
| 01/30/2002 | CN1078480C Somatostatin binding peptide-metal chelate conjugates |
| 01/29/2002 | US6342657 Expression cassettes and vectors for plant transformation; molecular hybridization; genetic engineering; activating site-specific recombination system in early embryo; promoter linked to recombinase gene |
| 01/29/2002 | US6342656 Regulation of source-sink relationships and responses to stress conditions in plants |
| 01/29/2002 | US6342655 Plants resistant to WT strains of cucumber mosaic virus |
| 01/29/2002 | US6342654 Gene expression promoter; eliciting hypersensitive response |
| 01/29/2002 | US6342596 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/29/2002 | US6342594 Determination of metastatic potential of cancer cells in test samples |
| 01/29/2002 | US6342593 Diagnosis and treatment of ALP related disorders |
| 01/29/2002 | US6342588 Conjugating biotin-tyramine label to proteins, peptides, or ligands comprising specific binding pair by use of hydrogen peroxidase enzyme; gene expression from modified nucleic acid; genetic engineering |
| 01/29/2002 | US6342586 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates and uses thereof |
| 01/29/2002 | US6342585 Method of activating denatured protein |
| 01/29/2002 | US6342584 Antiproliferative, anticarcinogenic, antitumor, antiinflammatory, and antimetastasis agents; diabetes, restenosis, rheumatoid arthritis treatment; genetic engineering |
| 01/29/2002 | US6342583 Polypeptide genetically expressed by cell that is transfected, infected, or injected with cloning vehicle; genetic engineering; colorectal cancer tumor markers |
| 01/29/2002 | US6342581 Genetic engineering and expression of polynucleotides and polypeptides; vectors, cells, antibodies for diagnosis and disease treatment |
| 01/29/2002 | US6342483 Method for detection and treatment of breast cancer |
| 01/29/2002 | US6342481 Oligopeptides derived from C-reactive protein fragments |
| 01/29/2002 | US6342476 Treating multiple sclerosis by administering a copolymer reacted with hydrobromic acid |
| 01/29/2002 | US6342392 Isolation of human and murine wild-type int6 gene cdna; cancer diagnosis; gene and immunotherapy; vaccines; gene expression |
| 01/29/2002 | US6342390 Integration of dna into chromosome of cell; does not generate virus particles; genetic expression and engineering |
| 01/29/2002 | US6342389 Modified phycobilisomes and uses therefore |
| 01/29/2002 | US6342385 Purified dna sequence encodes lantibiotic; drugs; genetic engineering |
| 01/29/2002 | US6342383 Reverse transcriptase activity; endogenous retroviruses |
| 01/29/2002 | US6342382 Purified nucleic acid; complementarity; washing follow hybridization; genetic engineering and expression |
| 01/29/2002 | US6342375 Modified methylotrophic Pichia pastoris yeast which secretes human growth hormone |
| 01/29/2002 | US6342374 Human collagenase inhibitor, recombinant vector system for using same and recombinant-DNA method for the manufacture of same |
| 01/29/2002 | US6342372 Culture to form protein using nutrients, isolation, culture of cells for expression of recombitant protein |
| 01/29/2002 | US6342371 Isolation polynucleotide and nucleotide sequences |
| 01/29/2002 | US6342370 Amino acid seqences and polynucleotides |
| 01/29/2002 | US6342369 Polypeptides, designated apo-2, which are capable of modulating apoptosis are provided |
| 01/29/2002 | US6342368 WD-40-derived peptides and uses thereof |
| 01/29/2002 | US6342363 Death domain containing receptor 4 nucleic acids and methods |
| 01/29/2002 | US6342362 Methods and compositions for the purification of proteins or other macromolecules |
| 01/29/2002 | US6342360 Dopamine receptors and genes |
| 01/29/2002 | US6342357 An isolated mutant dna; for diagnosis and therapy for cardiovascular disorders characterized by prolonation of the qt interval on electrocardiogram and the presence of syncope, seizures and sudden death |
| 01/29/2002 | US6342352 Method of detecting shigella and shigella mxiM DNA |
| 01/29/2002 | US6342351 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 01/29/2002 | US6342350 Alpha-2-macroglobulin diagnostic test |
| 01/29/2002 | US6342348 Neurturin receptor |
| 01/29/2002 | US6342233 Pseudomonas treatment composition and method |
| 01/29/2002 | US6342231 Haemophilus parasuis vaccine and diagnostic |
| 01/29/2002 | US6342229 Used in assays, in diagnostics and in immunotherap y and immunoprophylaxis |
| 01/29/2002 | US6342228 Diagnostic kits comprising genetically engineered human immunodeficiency virus-like particles containing heterologous antigenic markers |
| 01/29/2002 | US6342226 Administering antigen combined with a particulate vector, the particulate vector consisting of a non-liquid hydrophilic core for increasing the immunogenicity of an antigen |
| 01/29/2002 | US6342225 Pharmaceutical active conjugates |
| 01/29/2002 | US6342224 For prophylaxis and therapy of human papilloma induced tumours |
| 01/29/2002 | US6342223 Conjugate vaccine capable of conferring host immunity to an infection by group b streptococcus which comprises polysaccharide conjugated to protein |
| 01/29/2002 | US6342222 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 01/29/2002 | US6342221 Antibody conjugate compositions for selectively inhibiting VEGF |
| 01/29/2002 | US6342219 As anti-angiogenic and in tumor therapy |
| 01/29/2002 | US6342218 Method for treatment of SLE |
| 01/29/2002 | US6342215 Mutant microorganism having reduced adaptation to particular environment; avirulent pathogens for vaccines |
| 01/29/2002 | US6342201 Complex compounds for diagnosis of vascular diseases |
| 01/29/2002 | CA2226714C Method for identifying the attenuated varicella virus oka strain or a strain derived therefrom |
| 01/29/2002 | CA2176655C Stabilized composition of troponin for immunoassays and method of preparation of such a stabilized composition |
| 01/29/2002 | CA2158575C Chlamydia vaccine and process |
| 01/29/2002 | CA2155330C Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 01/29/2002 | CA2010776C Zn-, cu-, and mn-lactoferrins for promoting proliferation of useful microorganisms and suppressing proliferation of harmful microorganisms |
| 01/29/2002 | CA1341336C Neuropeptide y agonists |
| 01/28/2002 | CA2353115A1 Hvd1 gene induced by salt stress |
| 01/28/2002 | CA2352645A1 Compositions for dna transfection |
| 01/28/2002 | CA2315289A1 Plant promoter isolated from douglas-fir 2s seed storage protein gene |
| 01/24/2002 | WO2002006789A2 Multimeric biopolymers as structural elements, sensors and actuators in microsystems |
| 01/24/2002 | WO2002006537A2 Methods of identifying renal protective factors |
| 01/24/2002 | WO2002006534A2 Method of diagnosing pulmonary hypertension |
| 01/24/2002 | WO2002006531A2 Nucleic acid hairpin probes and uses thereof |
| 01/24/2002 | WO2002006501A2 Method for altering degradation of engineered protein in plant cells |
| 01/24/2002 | WO2002006499A2 Zmaxig1-specific polynucleotides and methods of use |
| 01/24/2002 | WO2002006497A2 Transplastomic plants |
| 01/24/2002 | WO2002006490A1 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 01/24/2002 | WO2002006487A2 Regulatory sequences from meristematic cells |
| 01/24/2002 | WO2002006483A1 Novel physiologically active peptide and use thereof |
| 01/24/2002 | WO2002006482A1 Receptor protein specifically recognizing bacterial dna |
| 01/24/2002 | WO2002006481A1 Target of anticancer agent |
| 01/24/2002 | WO2002006480A2 Tissue inhibitors of matrix metalloproteinases |
| 01/24/2002 | WO2002006479A2 Apoptosis-inducing dna sequences |
| 01/24/2002 | WO2002006478A2 Extracellular matrix protein |
| 01/24/2002 | WO2002006477A1 A novel polypeptide-homo topoisomerase 12.1 and polynucleotide encoding said polypeptide |
| 01/24/2002 | WO2002006476A1 A novel polypeptide, a human cytokine receptor 10.67 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006475A1 A NOVEL POLYPEPTIDE, A PREGNANCY SPECIFIC β 1-GLUCOPROTEIN 9.02 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
| 01/24/2002 | WO2002006474A1 A novel polypeptide, a human ehd protein 12.1 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006473A1 A novel polypeptide, a human estrogen receptor relative protein 10.01 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006472A1 A novel polypeptide, a human nucleoprotein 10.45 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006471A1 A novel polypeptide, a nucleophosmin9.68 and the polynucleotide encoding the polypeptide |
| 01/24/2002 | WO2002006470A1 A novel polypeptide, a human myoglobulin ixa11.88 and the polynucleotide encoding the polypeptide |